Vol. 2 No. 1 (2018)
Short Communication

Physician and Patient Attitudes Toward Screening for Kidney Complications in Type 2 Diabetes: Is There A Role for Patient Self-Advocacy?

Frischknecht B
Vennli Inc., Indiana, USA
Giudice L
Vennli Inc., Indiana, USA
Perkins RM
Bayer HealthCare, Whippany, New Jersey, USA
Urbany JE
Mendoza College of Business, University of Notre Dame and Vennli Inc., Indiana, USA
Published October 17, 2018


Urine protein screening rates among patients with type 2 diabetes are suboptimal despite evidence supporting its efficacy in preventing or slowing the progression of diabetic kidney disease (DKD). Testing of untimed urine specimens to quantify albumin (urine albumin-creatinine, or uACR)-the recommended screening test based on combination of simplicity, cost, and cardiovascular and renal prognostic value-is particularly underutilized, despite longitudinal efforts to improve awareness and screening among physicians.